Encompass Health Corporation $EHC Shares Sold by Van Lanschot Kempen Investment Management N.V.

Van Lanschot Kempen Investment Management N.V. cut its stake in shares of Encompass Health Corporation (NYSE:EHC) by 50.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 206,077 shares of the company’s stock after selling 214,015 shares during the quarter. Van Lanschot Kempen Investment Management N.V.’s holdings in Encompass Health were worth $21,873,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in EHC. Royal Bank of Canada grew its position in shares of Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after buying an additional 15,677 shares in the last quarter. Millennium Management LLC grew its position in shares of Encompass Health by 38.4% during the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after buying an additional 25,574 shares in the last quarter. Caxton Associates LLP acquired a new position in shares of Encompass Health during the first quarter worth about $259,000. Walleye Capital LLC grew its position in shares of Encompass Health by 667.6% during the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after buying an additional 7,671 shares in the last quarter. Finally, Gamco Investors INC. ET AL acquired a new position in Encompass Health in the second quarter valued at approximately $588,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on EHC shares. Barclays lowered their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. TD Cowen started coverage on Encompass Health in a report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price target for the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Encompass Health in a report on Monday. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $143.86.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC opened at $101.49 on Friday. The stock has a 50 day moving average price of $104.31 and a 200 day moving average price of $104.65. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. The company has a market capitalization of $10.07 billion, a price-to-earnings ratio of 16.94, a price-to-earnings-growth ratio of 2.23 and a beta of 0.72. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.09. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company’s revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Research analysts predict that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s dividend payout ratio is presently 12.69%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.